Orbimed Advisors Llc

13F Holdings History for CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX)

Symbol: CTMX on Nasdaq
Investment type: Equity / Common Stock, $0.00001 par value per share
Latest Disclosed Ownership: 8.46M shares
Security Ownership: 5.4%

Shares, Excluding Options vs Price

Value, Excluding Options

OrbiMed Advisors LLC ownership in CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX)

2025-08-14 - OrbiMed Advisors LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 8.46M shares of CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX). This represents 5.4% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
OrbiMed Advisors LLC	5.4%		$16.9M	8.46M			$2.00	13G	6/30/2025	14 Aug 2025 18:07:11

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0.48%	+0.48%	$19.2M	8.46M	+8,461,500	NEW	$2.27	Q2 2025
6/30/2024		-0.15%	$0	0	-3,544,578	-100%		Q2 2024
3/31/2024	0.14%	+0.17%	$7.73M	3.54M	+3,544,578	NEW	$2.18	Q1 2024
9/30/2022		-0.08%	$0	0	-2,124,975	-100%		Q3 2022
6/30/2022	0.07%		$3.89M	2.12M			$1.83	Q2 2022
3/31/2022	0.09%	-0.05%	$5.67M	2.12M	-1,089,534	-33.9%	$2.67	Q1 2022
12/31/2021	0.18%	+0.08%	$13.9M	3.21M	+1,392,641	+76.4%	$4.33	Q4 2021
9/30/2021	0.1%	+0.02%	$9.27M	1.82M	+308,700	+20.4%	$5.09	Q3 2021
6/30/2021	0.1%	+0.09%	$9.58M	1.51M	+1,513,168	NEW	$6.33	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.